Zhou C, Wu L, Fan Y, Wang Z, et al. Sintilimab plus platinum and gemcitabine as first-line treatment for advanced or metastatic squamous non-small-cell lung cancer: results from a randomized, double-blind, phase 3 trial (ORIENT-12). J Thorac Oncol 2021 May 25. pii: S1556-0864(21)02128.
PMID: 34048947